Analysis: Copycat biotech drugs slow to take off in Europe
LONDON (Reuters) - Despite austerity-driven cuts across European healthcare systems, most countries have been slow to embrace a new class of medicines...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/NQHKvVFwX2Q/story01.htm
This comment has been removed by a blog administrator.
ReplyDelete